Regular RELIABLE pricing discount information (For all European Markets)
- Discount levels per brand in each market
- Range of value added features and incentives that enhance the offer and contribute to overall "price"
The Reality - Extensive and significant pricing discounts are being applied to the European Hospital Market, meaning understanding the impact of Market Access for drugs and the traditional method of cashing out the European Hospital Expenditure is clearly somewhat inaccurate and flawed.
There is a significant requirement for a reliable, regular data source on insights into “real world” prices paid (typical discount levels offered to hospitals) on key pharmaceutical products, including other influencing factors.
Due to its personnel’s experience of previous price tracking studies within the European hospital sector, Next Research has been request by various clients to provide a statistically reliable, regular price tracking service which offers companies access to this critical, highly significant insights. Now Next Research would like to offer this data in a syndicated form.
Providing, syndicated and primary Quantitative reports of various discount levels (average, highest, lowest etc) in addition to qualitative aspects such as other influencing factors outside of price, such as opinions, stocking preference and the reasons why for choice etc.
Traditional methods of estimating competitors discounting practices based on in-house data can be misleading and does not convey the full actual competitive landscape. Read more >>
Through advanced analysis techniques we assess relative importance of different attributes in driving a company’s negotiating power, when price discounts are concerned. Read more >>
The contributing factors on negotiating discounts. Read more >>